Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sabrina Piedimonte

Showing results (21-30 of 38) with videos related to

Pageof 4
Sort By:
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|April 4, 2023
Validation of the Integrated Prediction Model algorithm for outcome of cytoreduction in advanced ovarian cancerSabrina Piedimonte, Marcus Q Bernardini, Avrilynn Ding, et al.
Acta Obstetricia Et Gynecologica Scandinavica|January 19, 2020
CA-125 reduction during neoadjuvant chemotherapy is associated with success of cytoreductive surgery and outcome of patients with advanced high-grade ovarian cancerRoy Kessous, Michel D Wissing, Sabrina Piedimonte, et al.
Gynecologic Oncology|July 12, 2022
Integrated prediction model of patient factors, resectability scores and surgical complexity to predict cytoreductive outcome and guide treatment plan in advanced ovarian cancerSabrina Piedimonte, Marcus Q Bernardini, Avrilynn Ding, et al.
Journal of Surgical Oncology|November 9, 2022
Using a machine learning algorithm to predict outcome of primary cytoreductive surgery in advanced ovarian cancerSabrina Piedimonte, Lauren Erdman, Delvin So, et al.
Gynecologic Oncology|May 4, 2021
Gynecologic oncology treatment modifications or delays in response to the COVID-19 pandemic in a publicly funded versus privately funded North American tertiary cancer centerSabrina Piedimonte, Sue Li, Stephane Laframboise, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|August 8, 2020
<i>BRCA</i> testing in women with high-grade serous ovarian cancer: gynecologic oncologist-initiated testing compared with genetics referralSabrina Piedimonte, Joanne Power, William D Foulkes, et al.
Current Oncology (Toronto, Ont.)|December 22, 2023
Combined Interval Cytoreductive Surgery and Carboplatin-Based Hyperthermic Intraperitoneal Chemotherapy in Advanced Primary High-Grade Serous Ovarian CancerClaudèle Brault, Alexandre Brind'Amour, Lara de Guerke, et al.
Journal of Surgical Oncology|July 12, 2022
Predicting recurrence and recurrence-free survival in high-grade endometrial cancer using machine learningSabrina Piedimonte, Tomer Feigenberg, Erik Drysdale, et al.
The Lancet. Oncology|January 20, 2012
Assessment of symptomatic women for early diagnosis of ovarian cancer: results from the prospective DOvE pilot projectLucy Gilbert, Olga Basso, John Sampalis, et al.
Annals of Surgical Oncology|August 12, 2024
Predictive Value of C-Reactive Protein for Infectious Complications After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: A Single-Center Prospective StudyJanyssa Charbonneau, Alexandre Brind'Amour, Lucas Sideris, et al.
Pageof 4

Showing results (21-30 of 38) with videos related to

Sort By:
Pageof 4
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|April 4, 2023
Validation of the Integrated Prediction Model algorithm for outcome of cytoreduction in advanced ovarian cancerSabrina Piedimonte, Marcus Q Bernardini, Avrilynn Ding, et al.
Acta Obstetricia Et Gynecologica Scandinavica|January 19, 2020
CA-125 reduction during neoadjuvant chemotherapy is associated with success of cytoreductive surgery and outcome of patients with advanced high-grade ovarian cancerRoy Kessous, Michel D Wissing, Sabrina Piedimonte, et al.
Gynecologic Oncology|July 12, 2022
Integrated prediction model of patient factors, resectability scores and surgical complexity to predict cytoreductive outcome and guide treatment plan in advanced ovarian cancerSabrina Piedimonte, Marcus Q Bernardini, Avrilynn Ding, et al.
Journal of Surgical Oncology|November 9, 2022
Using a machine learning algorithm to predict outcome of primary cytoreductive surgery in advanced ovarian cancerSabrina Piedimonte, Lauren Erdman, Delvin So, et al.
Gynecologic Oncology|May 4, 2021
Gynecologic oncology treatment modifications or delays in response to the COVID-19 pandemic in a publicly funded versus privately funded North American tertiary cancer centerSabrina Piedimonte, Sue Li, Stephane Laframboise, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|August 8, 2020
<i>BRCA</i> testing in women with high-grade serous ovarian cancer: gynecologic oncologist-initiated testing compared with genetics referralSabrina Piedimonte, Joanne Power, William D Foulkes, et al.
Current Oncology (Toronto, Ont.)|December 22, 2023
Combined Interval Cytoreductive Surgery and Carboplatin-Based Hyperthermic Intraperitoneal Chemotherapy in Advanced Primary High-Grade Serous Ovarian CancerClaudèle Brault, Alexandre Brind'Amour, Lara de Guerke, et al.
Journal of Surgical Oncology|July 12, 2022
Predicting recurrence and recurrence-free survival in high-grade endometrial cancer using machine learningSabrina Piedimonte, Tomer Feigenberg, Erik Drysdale, et al.
The Lancet. Oncology|January 20, 2012
Assessment of symptomatic women for early diagnosis of ovarian cancer: results from the prospective DOvE pilot projectLucy Gilbert, Olga Basso, John Sampalis, et al.
Annals of Surgical Oncology|August 12, 2024
Predictive Value of C-Reactive Protein for Infectious Complications After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: A Single-Center Prospective StudyJanyssa Charbonneau, Alexandre Brind'Amour, Lucas Sideris, et al.
Pageof 4